ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04390	Hippo signaling pathway	8/46	188/7206	2.06346796962e-05
ko04392	Hippo signaling pathway -multiple species	4/46	31/7206	4.03207496586e-05
ko04391	Hippo signaling pathway - fly	5/46	90/7206	0.000248784272154
ko04360	Axon guidance	6/46	233/7206	0.00339698122325
ko05410	Hypertrophic cardiomyopathy (HCM)	4/46	100/7206	0.00364550891701
ko04350	TGF-beta signaling pathway	4/46	103/7206	0.00405365637633
ko05414	Dilated cardiomyopathy	4/46	112/7206	0.00546197170204
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	2/46	19/7206	0.0063622939251
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3/46	79/7206	0.0137272601753
ko05212	Pancreatic cancer	3/46	83/7206	0.015670319936
ko05220	Chronic myeloid leukemia	3/46	85/7206	0.0166972350561
ko05210	Colorectal cancer	3/46	86/7206	0.0172246045168
ko05200	Pathways in cancer	7/46	492/7206	0.0348863239802
ko05166	HTLV-I infection	5/46	292/7206	0.0372733502463